SCHOENBERG MARK (Chief Medical Officer) sold 7.7% of their position (10K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $400.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/10/2026ACC: 0001437749-26-023290
Officer· Chief Medical Officer
Since Jan 2019
-10K
Net shares
Net seller
$400.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−10K
Price / share
$40.00
Trade value
$400K
% of position
7.7%
7/9/2026
129.76K→119.76K
Total
Net shares
−10K
Net value
-$400K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 7/9/2026 | S · Sale | −10K | $40.00 | $400K | 7.7% | 129.76K | 119.76K |
| Total | −10K | -$400K | ||||||
Derivative Transactions0
No derivative transactions reported